IulianaShapiraMD

Oncology • Little Silver, NJ

Cancer Genetics/Cancer Risk Assessment, Gastrointestinal Cancer, Hematologic Oncology

Associate Professor Medicine & Cell Biology State University of New York Brooklyn

Join to view full profile

Dr. Shapira is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shapira's full profile

Already have an account?

Office
180 White Rd
Little Silver, NJ 07739
Phone+1 732-530-8666

Fax+1 732-530-4139

Summary

I am a board certified oncologist, hematologist and internal medicine doctor. I have over a decade experience in Oncology Leadership both in Integrated private and academic oncology settings.

Education & Training

SUNY Downstate Health Sciences UniversityFellowship, Hematology and Medical Oncology, 2002 - 2005
Rutgers Health/Cooperman Barnabas Medical CenterResidency, Internal Medicine, 1995 - 1998
Carol Davila University of Medicine and PharmacyClass of 1990

Certifications & Licensure

NY State Medical License 2002 - 2026
CT State Medical License 2019 - 2025
MD State Medical License 2019 - 2025
NJ State Medical License 2019 - 2025
WY State Medical License 2019 - 2025
PA State Medical License 2019 - 2024
AR State Medical License 1997 - 2016
MS State Medical License 2001 - 2016
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Join now to see all

Awards, Honors, & Recognition

Top Oncologist Castle Connolly, 2020

Clinical Trials

A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

146 citations
International Society of Geriatric Oncology Chemotherapy Taskforce: Evaluation of Chemotherapy in Older Patients—An Analysis of the Medical Literature
Stuart M. Lichtman, Hans Wildiers, Etienne Chatelut, Christopher Steer, Daniel R. Budman
Journal of Clinical Oncology. 2007-05-10
151 citations
Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab.
Iuliana Shapira, Danieli Andrade, Steven L. Allen, Jane E. Salmon
Arthritis and Rheumatism. 2012-08-01
46 citations
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
Sara M Tolaney, Paolo Tarantino, Noah Graham, Nabihah Tayob, Laia Parè
The Lancet. Oncology. 2023-03-01

Press Mentions

Dr Iuliana Shapira Weighs in on How Data Analytics Can Improve Revenue CycleAugust 8th, 2019
Hopeful News for Cancer Patients from Iuliana Shapira, MD, RCCA's Chief Medical OfficerJuly 25th, 2019
® Announces the Institute for Value-Based Medicine® VB-Onc™ Meeting in New JerseyJune 6th, 2019
Join now to see all

Professional Memberships

American Society of Clinical Oncology - ASCO
Member